Latin America Pharmaceutical Contract Manufacturing & Research Services Market Size, Share & Trends Analysis Report By Service (Manufacturing, Research), By Country, And Segment Forecast, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Latin America Pharmaceutical Contract Manufacturing & Research Services Market Growth & Trends
The Latin America pharmaceutical contract manufacturing & research services market size is expected to reach USD 40.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 7.5% from 2022 to 2030. The low cost of drug registration in Latin American countries and the economic growth are the key factors contributing to progress in this region. Moreover, factors such as the growing demand for generics, rising investments in R&D, the growing geriatric population, and the increasing burden of chronic diseases are responsible for market growth. The outbreak of COVID-19 has boosted the market growth as companies have increased investments in R&D and manufacturing to develop vaccines and drugs against the COVID-19.
During the coronavirus outburst, the supply chains of biopharmaceutical companies remained robust and were largely unaffected worldwide. Similarly, contract manufacturers are observing a rise in demand for the production facilities which will be used in the COVID-19 vaccine and therapeutics. Thus, the future holds numerous growth opportunities in the market for pharmaceutical contract manufacturing & research service in Latin America.
For instance, in December 2021, under an agreement between Samsung Biologics and AstraZeneca, to manufacture Evusheld, which is an amalgamation of binary antibodies in development for the potential treatment of COVID-19. These factors are promoting the demand for CMOs and CROs in Latin American countries. The initiatives to decrease the commodity prices are expected to improve the region’s economic growth thereby boosting the revenue generation in the outsourcing market for pharmaceutical development.
Latin America Pharmaceutical Contract Manufacturing & Research Services Market Report Highlights
Latin America Pharmaceutical Contract Manufacturing & Research Services Market Growth & Trends
The Latin America pharmaceutical contract manufacturing & research services market size is expected to reach USD 40.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 7.5% from 2022 to 2030. The low cost of drug registration in Latin American countries and the economic growth are the key factors contributing to progress in this region. Moreover, factors such as the growing demand for generics, rising investments in R&D, the growing geriatric population, and the increasing burden of chronic diseases are responsible for market growth. The outbreak of COVID-19 has boosted the market growth as companies have increased investments in R&D and manufacturing to develop vaccines and drugs against the COVID-19.
During the coronavirus outburst, the supply chains of biopharmaceutical companies remained robust and were largely unaffected worldwide. Similarly, contract manufacturers are observing a rise in demand for the production facilities which will be used in the COVID-19 vaccine and therapeutics. Thus, the future holds numerous growth opportunities in the market for pharmaceutical contract manufacturing & research service in Latin America.
For instance, in December 2021, under an agreement between Samsung Biologics and AstraZeneca, to manufacture Evusheld, which is an amalgamation of binary antibodies in development for the potential treatment of COVID-19. These factors are promoting the demand for CMOs and CROs in Latin American countries. The initiatives to decrease the commodity prices are expected to improve the region’s economic growth thereby boosting the revenue generation in the outsourcing market for pharmaceutical development.
Latin America Pharmaceutical Contract Manufacturing & Research Services Market Report Highlights
- The manufacturing segment captured the largest share of about 66.3% in 2021, owing to the extensive range of services offered by the pharmaceutical CMOs for manufacturing drugs
- The API/bulk drug development services segment has held a dominant share in 2021, as pharmaceutical companies are making high investments in enhancing the API production capacity
- The inclination of pharmaceutical manufacturers to focus on core competencies rather than R&D is expected to boost the demand for contract research organizations in the region
- Government initiatives to ensure GMP compliance is expected to improve the demand for CMOs among the small and medium-sized pharma companies in the region
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. Country scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1:
1.9.2. Objective 2:
1.9.3. Objective 3:
1.9.4. Objective 4:
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Penetration & Growth Prospect Mapping
3.2. Industry Value Chain Analysis
3.2.1. Reimbursement framework
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.3.3. Industry challenges
3.4. Latin America Pharmaceutical Contract Manufacturing & Research Services Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies
3.4.5. COVID-19 Analysis
CHAPTER 4. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET: SERVICE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Definitions and Scope
4.3. Latin America Pharmaceutical Contract Manufacturing & Research Services Market Share, 2021 & 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Manufacturing
4.4.2. Research
CHAPTER 5. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET: COUNTRY ESTIMATES & TREND ANALYSIS
5.1. Country Market Dashboard
5.2. Country Market Share Analysis, 2021 & 2030
5.3. Country Market Share, 2020
5.4. Latin America
5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.2. Brazil
5.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.3. Argentina
5.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.4. Mexico
5.4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.5. Colombia
5.4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.6. Chile
5.4.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.7. Venezuela
5.4.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.8. Rest of Latin America
5.4.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.1.1. Lonza
6.1.1.1. Company overview
6.1.1.2. Financial performance
6.1.1.3. Service benchmarking
6.1.1.4. Strategic initiatives
6.1.2. Boehringer Ingelheim GmbH
6.1.2.1. Company overview
6.1.2.2. Financial performance
6.1.2.3. Service benchmarking
6.1.2.4. Strategic initiatives
6.1.3. Pfizer, Incorporated. (Pfizer CenterOne)
6.1.3.1. Company overview
6.1.3.2. Financial performance
6.1.3.3. Service benchmarking
6.1.3.4. Strategic initiatives
6.1.4. Charles River Laboratories International, Inc
6.1.4.1. Company overview
6.1.4.2. Financial performance
6.1.4.3. Service benchmarking
6.1.4.4. Strategic initiatives
6.1.5. Albany Molecular Research, Inc
6.1.5.1. Company overview
6.1.5.2. Financial performance
6.1.5.3. Service benchmarking
6.1.5.4. Strategic initiatives
6.1.6. Covance, Inc. (LabCorp)
6.1.6.1. Company overview
6.1.6.2. Financial performance
6.1.6.3. Service benchmarking
6.1.6.4. Strategic initiatives
6.1.7. QuintilesIMS
6.1.7.1. Company overview
6.1.7.2. Financial performance
6.1.7.3. Service benchmarking
6.1.7.4. Strategic initiatives
6.1.8. Pharmaceutical Product Development, LLC
6.1.8.1. Company overview
6.1.8.2. Financial performance
6.1.8.3. Service benchmarking
6.1.8.4. Strategic initiatives
6.1.9. Recipharm AB
6.1.9.1. Company overview
6.1.9.2. Financial performance
6.1.9.3. Service benchmarking
6.1.9.4. Strategic initiatives
6.1.10. AbbVie, Inc.
6.1.10.1. Company overview
6.1.10.2. Financial performance
6.1.10.3. Service benchmarking
6.1.10.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. Country scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1:
1.9.2. Objective 2:
1.9.3. Objective 3:
1.9.4. Objective 4:
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Penetration & Growth Prospect Mapping
3.2. Industry Value Chain Analysis
3.2.1. Reimbursement framework
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.3.3. Industry challenges
3.4. Latin America Pharmaceutical Contract Manufacturing & Research Services Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies
3.4.5. COVID-19 Analysis
CHAPTER 4. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET: SERVICE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Definitions and Scope
4.3. Latin America Pharmaceutical Contract Manufacturing & Research Services Market Share, 2021 & 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Manufacturing
4.4.2. Research
CHAPTER 5. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET: COUNTRY ESTIMATES & TREND ANALYSIS
5.1. Country Market Dashboard
5.2. Country Market Share Analysis, 2021 & 2030
5.3. Country Market Share, 2020
5.4. Latin America
5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.2. Brazil
5.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.3. Argentina
5.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.4. Mexico
5.4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.5. Colombia
5.4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.6. Chile
5.4.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.7. Venezuela
5.4.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.8. Rest of Latin America
5.4.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.1.1. Lonza
6.1.1.1. Company overview
6.1.1.2. Financial performance
6.1.1.3. Service benchmarking
6.1.1.4. Strategic initiatives
6.1.2. Boehringer Ingelheim GmbH
6.1.2.1. Company overview
6.1.2.2. Financial performance
6.1.2.3. Service benchmarking
6.1.2.4. Strategic initiatives
6.1.3. Pfizer, Incorporated. (Pfizer CenterOne)
6.1.3.1. Company overview
6.1.3.2. Financial performance
6.1.3.3. Service benchmarking
6.1.3.4. Strategic initiatives
6.1.4. Charles River Laboratories International, Inc
6.1.4.1. Company overview
6.1.4.2. Financial performance
6.1.4.3. Service benchmarking
6.1.4.4. Strategic initiatives
6.1.5. Albany Molecular Research, Inc
6.1.5.1. Company overview
6.1.5.2. Financial performance
6.1.5.3. Service benchmarking
6.1.5.4. Strategic initiatives
6.1.6. Covance, Inc. (LabCorp)
6.1.6.1. Company overview
6.1.6.2. Financial performance
6.1.6.3. Service benchmarking
6.1.6.4. Strategic initiatives
6.1.7. QuintilesIMS
6.1.7.1. Company overview
6.1.7.2. Financial performance
6.1.7.3. Service benchmarking
6.1.7.4. Strategic initiatives
6.1.8. Pharmaceutical Product Development, LLC
6.1.8.1. Company overview
6.1.8.2. Financial performance
6.1.8.3. Service benchmarking
6.1.8.4. Strategic initiatives
6.1.9. Recipharm AB
6.1.9.1. Company overview
6.1.9.2. Financial performance
6.1.9.3. Service benchmarking
6.1.9.4. Strategic initiatives
6.1.10. AbbVie, Inc.
6.1.10.1. Company overview
6.1.10.2. Financial performance
6.1.10.3. Service benchmarking
6.1.10.4. Strategic initiatives
LIST OF TABLES
Table 1 List of Abbreviation
Table 2 List of Secondary Sources
Table 3 Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Region 2018 - 2030 (USD Million)
Table 4 Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 5 Brazil Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 6 Mexico Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 7 Argentina Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 8 Colombia Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 9 Chile Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018-2030 (USD Million)
Table 10 Venezuela Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 11 Rest of Latin America, Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 1 List of Abbreviation
Table 2 List of Secondary Sources
Table 3 Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Region 2018 - 2030 (USD Million)
Table 4 Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 5 Brazil Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 6 Mexico Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 7 Argentina Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 8 Colombia Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 9 Chile Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018-2030 (USD Million)
Table 10 Venezuela Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
Table 11 Rest of Latin America, Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Latin America Pharmaceutical Contract Manufacturing & Research Services market : Market snapshot
Fig. 9 Latin America Pharmaceutical Contract Manufacturing & Research Services market : Market segmentation
Fig. 10 Latin America Pharmaceutical Contract Manufacturing & Research Services market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Latin America Pharmaceutical Contract Manufacturing & Research Services market driver impact
Fig. 14 Latin America Pharmaceutical Contract Manufacturing & Research Services market restraint impact
Fig. 15 Latin America Pharmaceutical Contract Manufacturing & Research Services market porter’s five forces analysis
Fig. 16 Latin America Pharmaceutical Contract Manufacturing & Research Services market PESTEL analysis
Fig. 17 Latin America Pharmaceutical Contract Manufacturing & Research Services market segment dashboard
Fig. 18 Latin America Pharmaceutical Contract Manufacturing & Research Services market: Service movement Analysis
Fig. 19 Manufacturing Latin America Pharmaceutical Contract Manufacturing & Research Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Research Latin America Pharmaceutical Contract Manufacturing & Research Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Latin America Pharmaceutical Contract Manufacturing & Research Services Market: Country movement analysis
Fig. 22 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Colombia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Chile market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Venezuela market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Rest of Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Latin America Pharmaceutical Contract Manufacturing & Research Services market : Market snapshot
Fig. 9 Latin America Pharmaceutical Contract Manufacturing & Research Services market : Market segmentation
Fig. 10 Latin America Pharmaceutical Contract Manufacturing & Research Services market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Latin America Pharmaceutical Contract Manufacturing & Research Services market driver impact
Fig. 14 Latin America Pharmaceutical Contract Manufacturing & Research Services market restraint impact
Fig. 15 Latin America Pharmaceutical Contract Manufacturing & Research Services market porter’s five forces analysis
Fig. 16 Latin America Pharmaceutical Contract Manufacturing & Research Services market PESTEL analysis
Fig. 17 Latin America Pharmaceutical Contract Manufacturing & Research Services market segment dashboard
Fig. 18 Latin America Pharmaceutical Contract Manufacturing & Research Services market: Service movement Analysis
Fig. 19 Manufacturing Latin America Pharmaceutical Contract Manufacturing & Research Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Research Latin America Pharmaceutical Contract Manufacturing & Research Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Latin America Pharmaceutical Contract Manufacturing & Research Services Market: Country movement analysis
Fig. 22 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Colombia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Chile market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Venezuela market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Rest of Latin America market estimates and forecast, 2018 - 2030 (USD Million)
